Skip to main content
. 2023 Aug 18;25(9):euad256. doi: 10.1093/europace/euad256

Figure 3.

Figure 3

Secondary outcomes after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy versus controls: (A) anti-arrhythmic drug use, (B) repeat atrial fibrillation ablation, and (C) recurrent atrial arrhythmias after repeat ablation(s).